MedTrace Logo

Angioedema Biomarker Research Study

NCT06210698 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-01-18

No results posted yet for this study

Summary

This clinical trial aims to evaluate and compare novel and commercially available diagnostic assays through blood tests for the differential diagnosis and comprehensive assessment of patients experiencing recurrent angioedema attacks, including both urticarial and non-urticarial angioedema. The primary objective is to assess the efficiency of novel diagnostic assays, both individually and in combination, in comparison to currently available commercial tests. The ultimate goal is to establish the feasibility of developing an affordable and accurate laboratory test capable of diagnosing the diverse etiological manifestations of angioedema.

Conditions

  • Angioedema
  • Angioedemas, Hereditary
  • Urticaria
  • Mastocytosis
  • ACE Inhibitor-Induced Angioedema
  • C1 Inhibitor Deficiency
  • Systemic Mastocytoses
  • Indolent Systemic Mastocytosis

Interventions

DIAGNOSTIC_TEST

Venipuncture

venipuncture

Sponsors & Collaborators

  • Institute for Asthma & Allergy

    collaborator UNKNOWN

  • Virant Diagnostics, Inc.

    collaborator UNKNOWN

  • MedBio Reference Laboratories, Inc.

    collaborator UNKNOWN

  • Foundation For Rare Disease Research

    lead OTHER

Principal Investigators

  • Lili Wan, PhD · Institute for Asthma & Allergy

Eligibility

Min Age
12 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2026-02-01
Completion
2026-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06210698 on ClinicalTrials.gov